EuroGentest: DNA-based testing for heritable disorders in Europe.
about
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersPoints to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.Postal survey of physicians and laboratories: practices and perceptions of molecular oncology testingAccess to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatmentEliciting preferences for priority setting in genetic testing: a pilot study comparing best-worst scaling and discrete-choice experiments.Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiencyPoints to consider in assessing and appraising predictive genetic tests.Quality standards and samples in genetic testing.Genetic testing: predictive value of genotyping for diagnosis and management of disease.The genetics and neuropathology of neurodegenerative disorders: perspectives and implications for research and clinical practiceClinical utility gene card for: Centronuclear and myotubular myopathies.Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most?Genetic testing in the European Union: does economic evaluation matter?Guidance for patients considering direct-to-consumer genetic testing and health professionals involved in their care: development of a practical decision tool.The EuroGentest clinical utility gene cards.Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom
P2860
Q22330767-ACCE26B6-7424-4DC4-80C8-368A20A14122Q27324818-95700C5F-8758-4E6B-95C0-ABA8BB4A4D8CQ30227715-3A68FD70-1F25-4AEF-BD7D-B5A8ACE03F92Q33763903-DB9F4A8C-26F8-47C4-A7B9-97A750E456FCQ34332744-0B023B88-3BCC-4BFB-A3CA-7465293064FFQ35230078-FD670659-45F2-4DE6-A1CE-38A8678BBB2CQ35263641-6355C05A-796C-4C42-B1A7-BDA8F6152475Q35914939-1D835A39-0BE2-4142-A4B9-C381E6D5E70EQ36117915-3ED65577-57EC-4357-A667-90A8DC8B4BA7Q36204070-5EA96C32-50D6-4C12-A8E5-4FC29C62B659Q36253416-E6417413-56B0-447D-BF68-CDF8B99E5950Q37397621-C46C6110-F1E6-48CF-8DED-A4B960ADBD23Q37877618-22396AE3-A21A-4E01-AC67-228BC65343E2Q39261577-2181B0D4-D30A-48B7-8217-129D78B196D6Q41734185-1033425E-7A92-4C66-A5DD-AF5E57350FE9Q57839586-986D0245-45C1-4EE1-B97A-9D2A239EA392
P2860
EuroGentest: DNA-based testing for heritable disorders in Europe.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EuroGentest: DNA-based testing for heritable disorders in Europe.
@en
EuroGentest: DNA-based testing for heritable disorders in Europe.
@nl
type
label
EuroGentest: DNA-based testing for heritable disorders in Europe.
@en
EuroGentest: DNA-based testing for heritable disorders in Europe.
@nl
prefLabel
EuroGentest: DNA-based testing for heritable disorders in Europe.
@en
EuroGentest: DNA-based testing for heritable disorders in Europe.
@nl
P2093
P2860
P356
P1476
EuroGentest: DNA-based testing for heritable disorders in Europe
@en
P2093
Helena Kaariainen
Irmgard Nippert
Jorg Schmidtke
Poupak Javaher
Ron Zimmern
Ulf Kristoffersson
P2860
P304
P356
10.1159/000111984
P577
2008-01-17T00:00:00Z